BIOL News and Press, Biolase Inc. From 03/22/24

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 4.2% to $0.1248 on volume of 179,379,334 shares Biolase Inc. (BIOL) rose 19.5% to $0.1793 on volume of 129,349,610 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.6% to $3.22 on volume o...

A look at the top 10 most actives in the United States Biolase Inc. (BIOL) rose 52.0% to $0.228 on volume of 76,448,685 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 8.5% to $0.1476 on volume of 32,191,096 shares Nova Lifestyle Inc (NVFY) rose 121.6% to $4.1 on volume of 32,...

2024-03-22 07:03:55 ET DENVER, Colo., Mar 22, 2024 ( 247marketnews.com )- BIOLASE, Inc. (NASDAQ: BIOL ) reported, after yesterday’s market close, its fourth quarter and full year 2023 financial results. BIOLASE achieved revenue growth in 2023, to $49.2 million, an increas...

2024-03-21 18:35:02 ET BIOLASE, Inc. (BIOL) Q4 2023 Earnings Call Transcript March 21, 2024, 04:30 PM ET Company Participants Todd Kehrli - IR, EVC Group John Beaver - President and CEO Jennifer Bright - CFO Conference Call Participants Bruce Jackson ...

2024-03-21 16:15:05 ET More on Biolase BIOLASE announces pricing of $7 million public offering Seeking Alpha’s Quant Rating on Biolase Historical earnings data for Biolase Financial information for Biolase Read the full article on Seeking Alp...

LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, who previously announced its preliminary financial results for the fourth quarter and full year ended December 31, 2023, today reported its financial results ...

X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...

2024-03-20 17:35:17 ET More on Biolase BIOLASE announces pricing of $7 million public offering Seeking Alpha’s Quant Rating on Biolase Historical earnings data for Biolase Financial information for Biolase Read the full article on Seeking Alp...

2024-03-17 08:20:00 ET Wall Street has reached a notable lull in the pace of quarterly releases. Still, investors are eagerly anticipating important announcements from FedEx ( NYSE: FDX ) and a set of prominent consumer brands, such as Nike ( NYSE: NKE ), Lululemon Athl...

LAKE FOREST, CA / ACCESSWIRE / March 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release fourth quarter and full year 2023 financial and operating results on Thursday, March 21, 2024, after the close of the U.S. ...